CEO
Stuart Long
Stuart Long serves as the Chief Executive Officer and President of SentiAR. Stuart brings an extensive track record scaling medical device and healthcare IT (HCIT) companies. As CEO of InfoBionic.Ai, he led the company through multiple rounds of growth in remote cardiac monitoring and FDA clearances, a Series D funding round, and a research collaboration with Mayo Clinic-portfolio company Anumana. Former CEO and senior commercial leader across the medical device and HCIT space, including at Monarch Medical Systems, CapsuleTech (where he helped drive its acquisition by Qualcomm Life), and Philips Healthcare, along with executive positions at Agfa Healthcare, AMICAS, FUJIFILM USA, and Eastman Kodak, plus earlier clinical experience in acute care and non-invasive cardiology. He holds a degree from Cornell University’s Johnson Graduate School of Management, with a focus in marketing strategy.
CMO & Co-Founder
Jennifer Avari Silva, MD
Jennifer Avari Silva is responsible for the clinical application of the SentiAR technology for patient use. She is an Asst. Professor of Pediatrics at Washington University in St. Louis and Director of Pediatric Cardiac Electrophysiology at St. Louis Children’s Hospital, where she leads the largest pediatric electrophysiology program in the Midwest. Dr. Avari Silva has published numerous papers bringing new technologies to pediatric patients, allowing her to develop an extensive industrial network with companies that include, St. Jude Medical, Medtronic, Biotronik, and Biosense Webster.
Her academic credentials include a BA from Union College, an MD from St. George’s University School of Medicine, residencies in Pediatrics at Miami Children’s Hospital, Pediatric Cardiology at Washington University School of Medicine, and in Pediatric Electrophysiology at Children’s Hospital Boston, Harvard University.
CTO & Co-Founder
Jonathan Silva, PhD
Jon created the SentiAR visualization platform and has oversight for the overall technical design and development to meet current and future clinical applications. It was his original work that secured over $500,000 in grants to build the initial prototype on the Microsoft Hololens platform for in-human engineering trials. As an Asst. Professor of Biomedical Engineering at Washington University in St. Louis, his research laboratory specializes in applying computational approaches to address problems in cardiac electrophysiology. Jonathan is part of the Cardiac Bioelectricity and Arrhythmia Center, and his academic preparation includes a BS from Johns Hopkins University, an MS from Case Western Reserve University, and a PhD in Biomedical Engineering, Washington University.
Chief Financial Officer
Claudia Drayton
Claudia Napal Drayton is an experienced public company CFO with a focus on healthcare, MedTech, and BioTech companies navigating IPOs, M&A, and other transformative events. She currently serves as Board Director and Audit Committee Chair at Brookdale (NYSE: BKD) and 3D Systems Corporation (NYSE: DDD). She also serves as a Strategic Advisor to Marani Health and as President of her own advisory practice, Kaixo Consulting LLC. Previously, she was Chief Financial Officer of Quantum-Si (NASDAQ: QSI), a life sciences company where she led financing and IPO-related work. She holds an MBA in Finance and Strategic Management from the University of Minnesota’s Carlson School of Management, completed executive education in Organizational Leadership at Wharton, holds an NACD Directorship Certification. She’s also active in advancing women and Latino representation on corporate boards, including through How Women Lead’s Get On Board program and the Latino Corporate Directors Association.
VP of Technology & Co-Founder
Michael Southworth
Michael is responsible for the company’s holographic platform validation, software planning, and team execution. Prior to joining the project, he developed 3D computer vision exploitation of sensor data for use in airborne platforms as an electrophysics scientist at Boeing Research and Technology. From 2007-2015 at the Johns Hopkins University Applied Physics Laboratory (JHUAPL), Michael specialized in the rapid development of embedded systems for direct deployment to the Department of Defense end users, primarily focused on the technical integration of wireless embedded systems with emerging microelectromechanical systems (MEMS) sensor technology, navigation, electro-optical sensor development and 3D sensor exploitation. Michael earned his BS from UC Berkeley and a dual MS from Johns Hopkins University.
VP of Quality & Regulatory Affairs
Alex Schreiner
Alex is responsible for the company’s regulatory, quality system, and project planning activities. Prior to joining SentiAR, he acted in senior leadership and individual contributor positions in start-up and established medical device companies, supporting product development and commercialization of implantable and surgical devices, electronic and software-containing devices, and external accessories for use by patients and physicians. Alex specializes in creative and efficient regulatory and quality system solutions to ensure safe, effective, and compliant products and processes and predictable regulatory body interactions. Alex earned his BS in neuroscience from the University of Minnesota.
